ATYR PHARMA INC (ATYR) Stock Cash Flow
NASDAQ:ATYR - US0021202025 - Common Stock
5.61 USD
+0.14 (+2.56%)
5.6 USD
-0.01 (-0.18%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -66.64M | -64.02M | -50.40M | -45.34M | -33.78M | |||
| Depreciation Amortization | 1.96M | 1.54M | 592.00K | 232.00K | 475.00K | |||
| Change In Working Capital | 8.02M | -6.92M | 15.01M | -833.00K | -2.59M | |||
| Interest Paid | 116.00K | 137.00K | 172.00K | 54.00K | 0.00 | |||
| Other non cash items | 1.06M | 281.00K | 1.57M | 4.06M | 2.81M | |||
| OPERATING CASH FLOW | -55.60M | -69.12M | -33.22M | -41.89M | -33.08M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -49.00K | -65.00K | -4.21M | -1.64M | -192.00K | |||
| Other Investing Activity | 10.79M | 17.30M | -15.91M | 48.89M | -91.37M | |||
| INVESTING CASH FLOW | 10.74M | 17.23M | -20.13M | 47.24M | -91.57M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -517.00K | -497.00K | -394.00K | -66.00K | 0.00 | |||
| Stock Issued/Repurchased | 55.78M | 40.36M | 66.62M | 5.52M | 110.03M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 55.26M | 39.86M | 66.23M | 5.45M | 110.03M | |||
| CHANGE IN CASH | 10.40M | -12.02M | 12.88M | 10.81M | -14.62M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -55.60M | -69.12M | -33.22M | -41.89M | -33.08M | |||
| Capital Expenditure | -49.00K | -65.00K | -4.21M | -1.64M | -192.00K | |||
| FREE CASH FLOW | -55.65M | -69.18M | -37.44M | -43.53M | -33.27M | |||
All data in USD